banner  
Cylex Logo ImmuKnow Logo Cylex Logo ImmuKnow Logo Cylex Logo ImmuKnow Logo Cylex Logo ImmuKnow Logo Cylex Logo ImmuKnow Logo Cylex Logo ImmuKnow Logo
 
spacer menuleft
HOME ABOUT CYLEX HEALTH CARE PROFESSIONALS PATIENTS INTERNATIONAL CUSTOMER CARE
menuright spacer
 
spacer
 

Patient Testimonial Video

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

spacer

 

 

spacer

Welcome to Cylex where we are committed to the continued advancement of transplant medicine.

Cylex is a global life sciences company focused on the development, manufacture and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. The Company has developed patented technology that provides an innovative platform to simply and reproducibly assess immune cell function, thus providing crucial insight for individualized transplant patient management.

This patented technology, as part of a global immune status monitoring strategy has been used to help identify kidney, liver, lung and heart transplant patients with low immune response – having the potential to lead to infection. Being in the know gives you crucial insight for individualized patient management.

Cylex

IMPORTANT Cylex Uses State Grant to Grow Internationally

IMPORTANT INFORMATION Reimbursement Rate Nearly Tripled for Cylex’s ImmuKnow® Assay

IMPORTANT FEATURE Find ImmuKnow near you.


Message from the President

Welcome to the Cylex Web Site

The principal goal of Cylex is to bring together the people and resources required to research, develop and market innovative, high quality products that clinicians can include in their transplant patient monitoring test strategy.  Our goal is to illuminate immunity to improve health.  We do that every day with ImmuKnow®, the only FDA-cleared assay that detects changes in global immune function over time.

This web site contains a wealth of information that will enable you to get to know ImmuKnow better. For example, you can learn about ImmuKnow and how it helps clinicians identify transplant patients at risk of infection due to over-immunosuppression by visiting the Health Care Professional section.  Or, if you are a patient interested in learning about ImmuKnow and how it provides your doctors with crucial insight for individualized patient management, you can visit the Patients portion of the site.  There are many ways to learn about Cylex and ImmuKnow – I invite you to explore them all.

Since the life sciences industry is fast-paced and ever changing, we make every effort to update our site frequently, so please come back often. And remember, we value your opinions.  We hope you enjoy your visit.

Sincerely,

Brad L. Stewart
Chairman, CEO and President
 
spacer
 

We Illuminate Immunity to Improve Health™

8980-I Old Annapolis Road, Columbia, MD USA 21045 • Tel 888.33.CYLEX • Fax 410.964.0367 • MD and International 410.964.0236
Copyright 2011 Cylex, Inc., All Rights Reserved • Last Updated January 2012
Privacy PolicyspacerSite MapContact Us

 
Cylex Logo ImmuKnow Logo